Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed

Brasil Notícia Notícia

Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 NPRHealth
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 63%

The Food and Drug Administration authorized Friday the emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.

Gilead is donating the first 1.5 million doses of remdesivir, but after that, the company has declined to say what remdesivir's price might be. During a conference call with investors on Thursday about first quarter earnings, analysts asked Gilead CEO Daniel O'Day whether they could expect similar returns on remdesivir as they've seen with the company's other products.

Taxpayers helped fund research for remdesivir and other potential vaccines and treatments, so Schakowsky added a line to the"The line in the bill essentially said that any drug that was made with any money from taxpayers would have to have reasonable pricing," she said. But, she added, a problem arose when another line made its way into the final bill that undercut the pricing assurance.

"It seems to me then that we are in a hostage situation if that's the view of the federal government and the people in charge," Schakowsky said."If this is what they want to extract from consumers in order to cure it, it's immoral. And it will end in a lot of deaths because people won't be able to afford their drugs."

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

NPRHealth /  🏆 144. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

FDA Authorizes Emergency Use of Gilead Drug Remdesivir for Covid-19 PatientsFDA Authorizes Emergency Use of Gilead Drug Remdesivir for Covid-19 PatientsThe Food and Drug Administration’s move came after researchers reported that the Gilead drug shortened the recovery times in people who have fallen ill from the new coronavirus.
Consulte Mais informação »

Navigating Injury and Pain During the COVID-19 Shutdown | HealthyWomenNavigating Injury and Pain During the COVID-19 Shutdown | HealthyWomenBy Melissa NeffThis story is part of our Real Women, Real Stories series, documenting the lived experiences of women along their health journeys. Please always consult your health care professional with personal concerns or questions.
Consulte Mais informação »

Prince Jackson Says His Dad Would Be 'Proud' of His Charitable COVID-19 ActionsPrince Jackson Says His Dad Would Be 'Proud' of His Charitable COVID-19 Actions'I was very fortunate to have him as a father,' the 23-year-old said of his late dad, Michael Jackson
Consulte Mais informação »

There Are Too Many Covid-19 Documentaries in the WorksThere Are Too Many Covid-19 Documentaries in the WorksYou know what I’d love to watch right now? A movie about covid-19. Or better yet, what about 20 movies about covid-19!
Consulte Mais informação »

Coronavirus updates: Potential COVID-19 treatment shows 'glimmer of hope,' researcher saysCoronavirus updates: Potential COVID-19 treatment shows 'glimmer of hope,' researcher saysLATEST: Free face coverings are being distributed at high-trafficked parks and hard-hit communities in New York City, Mayor Bill de Blasio says.
Consulte Mais informação »

Fact check: COVID-19 may be 'here to stay,' even after a vaccineFact check: COVID-19 may be 'here to stay,' even after a vaccineExperts say it's too soon to say for sure, but it's unlikely a vaccine will fully eradicate the virus.
Consulte Mais informação »



Render Time: 2025-03-10 19:24:11